Amgen
AMGN
240,49 €
Share price
-1.89%
Change (1 day)
-5.66%
Change (1 year)
Categories
The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
Revenue for Amgen (AMGN)
Revenue in 2024 (TTM): €31.06 Billion
According to Amgen's latest financial reports the company's current revenue (TTM 
) is €28.98 Billion. an increase over the revenue in the year 2023 that were of €25.50 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Amgen from 1996 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | €32.11 B | 25.96% |
| 2023 | €25.50 B | 3.92% |
| 2022 | €24.53 B | 6.98% |
| 2021 | €22.93 B | 10.98% |
| 2020 | €20.67 B | -0.88% |
| 2019 | €20.85 B | 0.47% |
| 2018 | €20.75 B | 9% |
| 2017 | €19.04 B | -12.88% |
| 2016 | €21.85 B | 10.33% |
| 2015 | €19.81 B | 20.1% |
| 2014 | €16.49 B | 21.98% |
| 2013 | €13.52 B | 3.61% |
| 2012 | €13.05 B | 8.78% |
| 2011 | €11.99 B | 6.02% |
| 2010 | €11.31 B | 10.74% |
| 2009 | €10.21 B | -4.77% |
| 2008 | €10.73 B | 6.08% |
| 2007 | €10.11 B | -6.44% |
| 2006 | €10.81 B | 3.05% |
| 2005 | €10.49 B | 34.92% |
| 2004 | €7.77 B | 17.19% |
| 2003 | €6.63 B | 27.46% |
| 2002 | €5.20 B | 16.18% |
| 2001 | €4.48 B | 20.96% |
| 2000 | €3.70 B | 16.37% |
| 1999 | €3.18 B | 43.01% |
| 1998 | €2.22 B | 12.64% |
| 1997 | €1.97 B | 6.71% |
| 1996 | €1.85 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | €55.18 B | 90.36% | 🇺🇸 USA |
 | €41.89 B | 44.51% | 🇺🇸 USA |
 | €34.84 B | 20.21% | 🇬🇧 UK |
 | €24.93 B | -13.97% | 🇺🇸 USA |
 | €8.39 B | -71.05% | 🇺🇸 USA |
 | €48.85 B | 68.54% | 🇺🇸 USA |
 | €77.03 B | 165.74% | 🇺🇸 USA |
 | €3.79 B | -86.92% | 🇺🇸 USA |
 | €39.06 B | 34.76% | 🇺🇸 USA |